ArticleOncology letters2026

Investigation of CRP and NLR as potential biomarkers for redefining biological borderline resectable pancreatic cancer.

Keishi Kawasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.